Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +251.5% | -256.7% | 2 / 3 | -9.6% | -33.40 pp | +19.01 pp | -7.7% | 0.14 | — | 12,3 | −9,6% | 1,5 | +251,5% | — | 11.31 | — |
| Pts | 12 | 0 | 8 | 0 | 0 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 2.630 (close price on 2026-10-19)EPS (TTM): −791,3
Financial charts
1.Revenue & growth
VND bn12,3Q2/26
1.Revenue & growth
VND bn12,3Q2/26
2.Profit & growth
VND bn1,44Q2/26
3.Profit mix (Penman)
VND bn-66,7Q2/26
4.Margins & cost structure
%-8.5%Q2/26
5.Returns & cash cycle
% · days-1.1%Q2/26
6.Earnings quality & cash
VND bn3,51Q2/26
7.Asset structure
VND bn979Q2/26
8.Funding & debt health
VND bn · times979Q2/26
9.Revenue backlog
VND bn0,55Q2/26
10.Valuation
times · %-2,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %17Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-1083%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26